Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 11Breast 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Subclinical Breast Cancer Lesion 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Gadolinium × Breast × Clear all
NCT06512558 2025-12-31

AR-GBS

Centre Jean Perrin

Phase NA Recruiting
20 enrolled
Breast

Subclinical Breast Cancer Lesion

NCT02587663 2019-05-16

Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI

University of Southern California

Phase NA Completed
300 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡